Evaluation of the efficacy, safety, and side effects of secukinumab in patients with moderate-to-severe psoriasis: real-world data from a retrospective multicenter study Ilteris Oguz Topal, Sevim Baysak, İlknur Kıvanç Altunay, Asude Kara Polat, Eylem Emel Arıkan, Ezgi Özkur, Sema Aytekin, Bilal Dogan, Tuğba Özkök Akbulut, Filiz Topaloğlu Demir, Ayşe Serap Karadağ

Risankizumab and guselkumab for psoriasis: a 1-year real-world practice indirect comparison Leyla Baykal Selçuk, Hande Ermiş Akkuş, Burak Akşan, Deniz Aksu Arıca

Blood microRNA expressions in patients with mild to moderate psoriasis and the relationship between microRNAs and psoriasis activity Emine Tugba Alatas, Murat Kara, Gursoy Dogan, Aslı Akın Belli